Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028324

Chief Financial Officer bought 1,250 shares at $18.22 ($22,775)

From the SEC's structured data for this filing

Trades in this filing

Ruffo Frank · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-07 Purchase : show line 1 in the form +1,250 $18.22 $22,775 156,865 D
Open-market purchases · 1,250 sh · avg $18.22 · $22,775
Loading xslF345X03/doc4.xml…